chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a Registered Nurse refers to a 12 month old patient of unknown gender. The nurse reported that the patient received a dose of VARIVAX (Merck) (lot # unspecified) (route, dose and location unspecified) on 12-JUN-2002 and then vaccinated with a dose of MMR II (lot # unspecified) (HSA) (route, dose and location unspecified) on 25-JUN-2002. The patient had received VARIVAX (Merck) and MMR II at different times within a period less than 28 days. No adverse effect reported. Follow up has been received from the Registered Nurse. It was reported that there was no problem with this child and there was no problem with the product. These vaccinating dates were not given by their facility. They were called to about collecting the problem. VARIVAX (Merck) was given on 12-JUN-2002 and MMR II on 25-JUN-2002. It was too close. MMR II (lot # not reported) (dose and route not reported) was given on 07-OCT-2013 to correct. This is one of several reports received from the same reporter. It was linked to MARRS # 1310USA001833 and MARRS# 1310USA001834. Additional information is not expected.
Patient received PNEUMOVAX vaccine Lot # K010522 in left deltoid. Came back to pharmacy 2 hrs later complaining of pain in left arm and was taken by EMS to hospital.
Ischemic stroke. Started about 11am Saturday morning, I was released from the hospital Sunday night and continue to have symptoms until today. I have vomiting,  instability, unbalanced, I couldn't move without falling or vomiting.  DR. (Neurologist) DR. (Attending)
when injecting patient on left arm with Moderna booster, med leaked due to faulty needle. Less than half dose was administered so I re administer another dose to the right arm
Narrative: COVID infection following COVID vaccine series 01/15, Pfizer, dose #1 02/16, Pfizer, dose #2 08/10 COVID swab, result: detected 08/05 pt cc: syncope, rhinorrhea exposure: unknown 08/06-08/16 Pt symptoms continue
patient bled, and a proportion of vaccine in the syringe was not administered; patient bled, and a proportion of vaccine in the syringe was not administered; This is a spontaneous report from a contactable pharmacist. A patient of unspecified age and gender received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot/batch number and expiration date not provided), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) at single dose for COVID-19 immunization. The pharmacist had a question regarding incomplete administration of 2nd dose of bnt162b2. While one patient was given a vaccine, patient bled, and a proportion of vaccine in the syringe was not administered on an unspecified date. The pharmacist asking was there any information about giving a third dose to those who received invalid second dose. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on temporal association, the causal relationship between bnt162b2 and the event haemorrhage cannot be excluded. The information available in this report is limited and does not allow a medically meaningful assessment. This case will be reassessed once additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.
Itchy eyes, sore throat, hoarseness, tiredness lasting eight days (so far).
Systemic: Allergic: Anaphylaxis-Medium, Systemic: Dizziness / Lightheadness-Severe, Systemic: Fainting / Unresponsive-Severe, Systemic: Hypotension-Medium, Systemic: Seizure-Mild, Additional Details: Per Nurse: Patient was given Pfizer and flu shot two minutes later.  Fifteen seconds later patient fell.  He stood up and sat down but fainted a second time.  Nurse stated she thought patient may have had seizure.  BP was 84/89.  Was given Epipen.  Paramedics soon arrived.  Patient stated he felt faint and was taken to Hospital on gurney.  Called mother and she states patient has receovered and is being monitored by MD.  Mother stated MD stated that patient was doing well.
This was a booster shot. By 10 am (16 hours later) I had shooting pains into my hear, up the side of my face into my head on the left side and squeezing sensation in my chest. The shooting pains lasted for about a day or so. The pinching sensation lasted for a week or two and was intermittent. I halted all physical activity. In addition now have terrible tinnitus. It began with in days of the shot and has not resolved. Both ears. Also my gut has experienced a return of mild gastroparsis resulting in nausea after eating and a slow motility. As such constipation.
Minimal arm sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Minimal arm sore) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced VACCINATION SITE PAIN (Minimal arm sore). At the time of the report, VACCINATION SITE PAIN (Minimal arm sore) outcome was unknown.            No concomitant medications reported. No treatment medications reported.   This case was linked to MOD-2021-375103.
got extremely sick from the shots; Initial information regarding this unsolicited valid non-serious case was received from a consumer via social media on 08-Oct-2020.  This case is linked to case 2020SA294157, 2020SA294125 (same source).  This case involved an unknown age male patient who got extremely sick from the shots (Illness), while he received vaccine influenza vaccine.  Medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number and expiration date not reported) via unknown route in unknown administration site for prophylactic vaccination.  The patient had several shots when the patient was in the military.  On an unknown date, the patient got extremely sick from the shots (Illness), (unknown latency) following the administration of INFLUENZA VACCINE.  The patient said he was never sicker in his whole life.   It was not reported if the patient received a corrective treatment.  The outcome was reported as unknown.
Shot administered 10/9/13. Patient came back on 10/12/13 with redness, slight swelling at site of injection.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medications were reported.   Reporter did not allow further contact
Symptoms = Swelling in deltoid Signs = Swelling Time Course = within minutes Treatment = Sent to ED, arm was iced. pt discharged.
Information has been received from a RN concerning a 35 yr old female with no medical history and no allergies who on 07Jul04 was vaccinated with a dose of measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3). Concomitant therapy included a dose of diphtheria toxoid/tetanus toxoid. On 15Jul04 the pt developed an itchy rash, temp of 103, achy body, mild sore throat and eyes that were painful. On 18Jul04 the rash was noted to be moving down the body and was on the torso, arms and upper legs. On 19Jul04 the pt did not look ill, had no fever and felt well. The rash still existed and was a little itchy, mostly in the scalp. The pt was negative for Koplick spots in the mouth. Unspecified medical attention was sought and no treatment was required. It was noted that the pt was not recovered from the rash. It was also reported that on 15Jul1998 the pt was vaccinated with a dose of rubella virus vaccine live (HPV 77). She has two children (3 yrs and 8 yrs) who were both vaccinated with  measles virus vaccine live  (Moraten) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3)  per the recommended schedule. No product quality complaint was involved. Additional information has been requested.
Redness, pain, and swelling bilaterally in deltoid areas. Started the day after immunization. 2 days before visit to MC. Treatment - Ibuprofen 400mg and ice.
During Covid-19 facility audit, it was brought to our attention this individual was not of the recommended age to receive this vaccine.
This spontaneous report as received from a Registered Nurse refers to a multiple unspecified patients of unknown age and gender, who on an unknown dates were vaccinated with a dose of GARDASIL (dose, indication, route, site of administration, and lot # were not reported), that might have been subjected to significant light exposure. No adverse effect reported. This is one of several reports received from the same source. Additional information has been requested.
Vaccine recipient developed mild nausea, acid reflux,  and stomach pain 10 minutes after vaccine administration. Vaccine recipient then developed nasal congestion and cough at 19 minutes, and then shortness of breath at 21 minutes. The vaccine recipient was then sent to the emergency department. While in the emergency department it was determined that the vaccine recipient had an allergic reaction. When vaccine recipient had shortness of breath the oxygen saturation went to 89-90%. The vaccine recipient received albuterol, diphenhydramine, famotidine, methylprednisolone, and fluids. During re-examination, the vaccine recipient?s condition improved and stable. Vitals were within normal limits. 89-90. They were discharged to home. At follow-up phone call on 12/23/2020, the vaccine recipient reported that they felt much better but was still experiencing voice hoarseness.
This spontaneous report as received from a medical assistant refers to 13 month old patient of unknown gender. On an unknown date in April 2014, between 12-APR-2014 and 24-APR-2014, the patient was vaccinated with a dose of VARIVAX (Merck) lot # J012210, expiry 28-SEP-2015 ("VFC" stock), 0.5 ml, once, intramuscular. The medical assistant stated there was a power outage on 12-APR-2014 and the VARIVAX (Merck) doses from the freezer needed to be transported to unspecified hospital for proper storage. She stated VARIVAX (Merck) was exposed to 46F for 1 hour, at worst. There were no prior excursions. There was a site visit from local health department on an unreported date. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
73 yr old man with medical hx significant for DM, HTN, CAD, depression, GERD, DJD, BPH, disseminated superficial actinic porokeratosis and allergies to dust and piroxicam received ZOSTAVAX injection on 5/29/08. Pt seen in ER on 5/31/08 with bad rash all over body (trunk/arms/legs) which is related to ZOSTAVAX. There is no lip/tongue involvement, no fever and rash is not helped with Diphenhydramine. Pt is treated with loratadine/ranitidine/hydroxyzine. Over the next several days pt is seen in urgent visit clinic twice for continued pruritic rash that is not helped with above treatments. Pt is given doxepin on 6/2/08 visit and during exam noted to have the following-confluent erythematous plaques, few excoriations, plaques on upper extremities to wrists, band across lower abdomen and involvement in flanking/achilles. Of note, pt without hx of chicken pox. Confirmed with reporter. Pt had varicella rash.
This case was reported by a pharmacist and described the occurrence of injection site soreness/tenderness in a 51-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 17 October 2011 the subject received a dose of FLUARIX (.5 ml, unknown route, left deltoid). Between 17 and 19 October 2011, less than one week after vaccination with FLUARIX, the subject experienced injection site soreness/tenderness and injection site warmth. The subject was treated with ibuprofen. At the time of reporting the events were unresolved. The pharmacist considered the events were possibly related to vaccination with FLUARIX.
Dizziness, Palpitations, HYPOtension, Tachycardia, Feeling falling and losing balance.
102.9 degree fever while taking acetaminophen. Severe chills and aches.
Patient stated prior to vaccine that she had itching and throat tightness after her first Pfizer vaccine from Pharmacy. It was resolved by PO Benadryl. Patient took 25 mg Benadryl PO prior to receiving 2nd Pfizer vaccine. After vaccine, patient reported throat tightness, mouth tingling, and shortness of breath. Epipen 0.3mg SubQ was administered. Patient taken to ER. Given methylprednisolone 125mg x 1 before discharge from ED with prednisone prescription.
In December I had atrial fibrillation with rapid ventricular response. I went to the emergency room. I had a lot of blood work done, EKG, CT scan, I honestly cannot remember all of the test they had to run. The test came back showing I had abnormal heart rhythm and was in atrial fibrillation. My cardiologist was called in, after looking at the test and consult it decided that I needed to have a pacemaker put in. I have since had to return to the hospital due to problems with my pacemaker. I also returned for fluid in my lungs that I need to have drained.
PATIENT REPORTED CHEST PAIN AFTER MODERNA SPIKEVAX, SORE ARM, AND GENERAL UNWELLNESS
C/o pain after injection. 10/11 awoke with leg swollen. Seen 10/12 with superficial redness 8cm x 11cm over medial aspect of L upper leg. 2mm papule at site of vaccine. Started on cephalexin. 10/14-still minimal swelling, minimal redness. Pustule dry.
numbness and tingling in lower extremities and achy bones Patient tool Tylenol with some relief, recommended to continue taking Tylenol as directed, drink plenty of fluids, rest and elevate legs. Advised if symptoms worsen contact MD.
Within hours of shot, lots of pain in shoulder, swelling in shoulder, weakness and unable to move the arm where shot was given without assistance from other arm. Accompanied by fever between 99 and 100 degrees F. Doctor's office prescribed Advil and Benedryl. Took both. Now on day 2. Still have 99.5 fever.  Arm still sore, but able to move it independently today. Tiredness. Mild headache. In process of recovering. Feeling better today than yesterday.
Patient received the Shingrix vaccine on 08/26/2021, and within two weeks, she was covered with hives and had severe pruritus. The reaction began in her legs and gradually went up her body. she now has to receive monthly injections of omalizumab (Xolair, 150 mg in each arm), an anti-lgE biologic, to control the hives and angioedema that have kept recurring since the original reaction. She states her allergist told her she has developed an autoimmune condition and may need to receive indefinite treatment.
Information has been received from a medical assistant concerning a patient who in approximately February 2010, "about two months ago", was vaccinated with a dose of PNEUMOVAX 23 (lot # 665300/1314Y or 663012/1163X). Subsequently after receiving PNEUMOVAX 23, the patient developed cellulitis. It was also reported that the patient required an MRI due to continuing nerve problems (results not provided). The patient sought medical attention by an office visit. At the time of the report, the outcome of the patient was unknown. This is one of several reports received from the same source. Additional information has been requested.
Lightheaded/dizziness; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Lightheaded/dizziness), HEADACHE (Headache) and NAUSEA (Nausea) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced DIZZINESS (Lightheaded/dizziness), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Lightheaded/dizziness), HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant and Treatment medications were not provided by the reporter.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 52-year-old patient received BNT162b2 (BNT162B2), on 15Mar2021 at 18:00 as dose 1, single (Lot number: EN6107), in left arm, on 05Apr2021 at 18:00 as dose 2, single (Lot number: ER8734), in left arm, on 23Nov2021 as dose 3 (booster), single (Lot number: 3303080), in left arm and on 21May2022 as dose 4 (booster), single (Lot number: FMOR13), in left arm for covid-19 immunisation. The patient's relevant medical history included: "Psoriatic arthritis" (unspecified if ongoing). It was reported that patient had no known allergies. Concomitant medication(s) included: SULFASALAZINE, start date: 31Jan2020. Patient took Greenstone as other medication in 2weeks on 31Jan2020.  The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 25Jun2022, outcome "not recovered" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Unknown results; (25Jun2022) Positive, notes: Started getting symptoms back on Saturday 25Jun, still testing positive on Sunday 26Jun; (26Jun2022) Positive, notes: Started getting symptoms back on Saturday 25Jun, still testing positive on Sunday 26Jun. Therapeutic measures were taken as a result of vaccination failure, covid-19.
entire body started breaking out in bright red rash - spread quickly + itching within 10 minutes of immunization - Refused EMT rash intensified!
aches; chills; fatigue; A spontaneous report was received from a  Consumer concerning a unknown Year-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events like myalgia, fatigue and chills.   The patient's medical history was not provided. No relevant concomitant medications were reported.    On 19-JAN-2021, prior to the onset of the events, the patient received their second planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the Anatomical location for prophylaxis of COVID-19 infection.  On 19-JAN-2021, The patient experienced the events like aches, chills and fatique. The patient became fine after 24 hours.  Action taken with mRNA-1273 in response to the events was not reported.   On unknown date the outcome of the events aches chills and fatigue was resolved. At the time of this report, the outcome of the events like aches , chills and fatigue was resolved
sick; a elevated heart beat; sick; Nausea; Vomiting; Fatigue; Dizziness; This is a spontaneous report from a contactable other hcp (patient) from a Pfizer Call Center. A 36-years-old female patient received BNT162B2(PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: EW0153; Expiration Date: 20Jul2021), dose 1 via an unspecified route of administration, administered in left arm on 28Apr2021 15:00 as 1st dose, single (at the age of 36-years-old) for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient had no prior Vaccinations within 4 weeks. After vaccination on 28Apr2021, patient was sick and had a elevated heart rate since then, it is not as bad as it was but it is still higher than normal levels. and also had nausea, vomiting, fatigue, and dizziness; these events were gone three days later. On 19May2021, patient was scheduled to receive her second dose, but missed it as she was feeling sick again. Patient had a visit to Physician Office. Patient reported she had lab work since then but does not specify type or results. No Investigation Assessment. Patient was recovering from elevated heart beat, the outcome of feeling sick was unknown and recovered from rest of the events on 01May2021.  Follow-up actions are needed. Further information has been requested.
Occurred over 3 days:nausea, tunnel vision, ringing in the ears, lightheadedness, racing pulse, clamminess but not diaphoresis.  Pain, heat induration, redness and itching at injection site.  Itching from injection site moving up arm to neck, side of face and hair.  Itching to inside of mouth and lips.  Feeling of heaviness and weakness to arms and legs.  Chest heaviness and increased work of breathing.  I wasn?t breathing faster, but I was aware of the fact that I had to work harder to breath.  As I said, these symptoms occurred over three days.  The Friday I went to the ED at Hospital.  I arrived around 14:45 and I think it was somewhere around 20:30 when I left.
Pt recvd vax 23JUL92 & w/in 24 hrs pt devel a temp of 101 & exp h/a, myalgia, nausea, & photophobia; 29JUL92 devel RRL pneumonitis; On the same day, lab eval revealed a nl CBC:
First three days, tired and sore arm. Hot at injection site. 5 days of feeling normal and fine. Today, January 28th, 8 days after injection - Hives around injection site only, nowhere else on body. Hot, painful to touch, swollen, fairly big lump in arm. Bigger than original injection bump. Headache.
Fatigue, poor sleep, achy muscles, dehydration, head ache. Chills. Generally feeling crummy.
Had area of induration and irritation at site of Varicella Vaccination that is improving.